LONDON – It may be possible to develop a drug that will prevent white blood cells from entering the inflamed synovial joints that occur in rheumatoid arthritis, where they cause further damage and inflammation, a new study suggested.
LONDON – While looking for a target that could be blocked to prevent the malaria parasite from multiplying in the blood of its human host, researchers serendipitously identified a molecule that stops the parasites from reproducing in the mosquito.
LONDON – A type of drug that is already being evaluated as a treatment for Huntington's disease could have a valuable side effect that would also help reduce the progress of the condition, a new study suggested.
LONDON – A new understanding of interactions between bacterial proteins could lead to novel antibiotics that halt the discharge of toxins into host cells.
LONDON – The discovery of a genetic variant that is associated with a higher risk of developing a particular type of stroke could one day lead to new treatments for that condition.
LONDON – A new method of probing the mechanisms of drug resistance in unicellular parasites has identified a tranche of genes and proteins that may make it possible to develop new treatments for hitherto difficult-to-treat infections.
LONDON – Blocking a receptor molecule on natural killer (NK) cells in mice can protect the animals from serious viral infections that would normally kill them, researchers have shown.
LONDON – The discovery of a new way to prevent cells from producing tumor necrosis factor (TNF) could one day lead to the development of more specific treatments for conditions such as rheumatoid arthritis, Crohn's disease and sepsis.
LONDON – A protein that can steer the estrogen receptor protein to different parts of the genome in cancer cells probably helps to determine the outcome of breast cancer, a new study has found.
LONDON – The identification of a gene that plays an important role in the development of the pancreas will give a boost to efforts to create insulin-producing pancreatic beta cells for the treatment of Type I diabetes.
